68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer

NCT03389451 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Prostatic Neoplasm
Prostatic Neoplasms, Castration-Resistant
Prostatic Cancer Recurrent
Prostatic Cancer Metastatic

Interventions

DRUG: Ga-68 PSMA-HBED-CC PET

Sponsor

Michael Graham PhD, MD

Collaborators

[object Object]
[object Object]